Search

everythinglearnresearchcommunity

for

Search:↓

Higher disease activity in systemic lupus erythematosus is strongly linked to more internal organ damage.

Alopecia negatively affects quality of life and mental health.

The STRIAA tool helps doctors quickly and effectively assess the severity of Alopecia Areata.

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

Alopecia areata affects many in the US, impacting quality of life, with limited treatment options.

Young men with early hair loss and high SAA3 levels are at higher risk for heart disease.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Higher IL-17A levels indicate more severe alopecia areata.

Men with hair loss experience lower quality of life, worsened by factors like age, severity, and treatment history.

The Spanish version of the Hair Specific Skindex-29 scale is a reliable and valid way to measure the impact of hair loss on women's quality of life.

Hair loss may indicate higher risk of heart disease.

Yellow dots are common in severe alopecia areata.

Acne and hair loss in women can greatly lower their quality of life, but having polycystic ovarian syndrome does not.

Higher MPV and CRP levels may indicate more severe alopecia areata.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Integrating ABI screening in clinics can improve patient care for those at risk of peripheral artery disease.

Alopecia areata greatly affects quality of life, with many experiencing mental health issues and lacking professional support.

Higher monocyte counts may predict poor response to adalimumab in hidradenitis suppurativa patients.

Fibromyalgia slightly more common in SLE patients but doesn't affect SLE activity assessments.

Androgenetic alopecia negatively affects quality of life and self-esteem, especially in women, but not depression.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Certain scalp patterns can indicate the severity and activity of hair loss in Turkish alopecia patients.

The Breast Utility Instrument was developed to assess quality of life in breast cancer patients.

Wigs significantly improve the well-being of people with severe hair loss.

Hair loss from alopecia areata and androgenetic alopecia moderately affects the quality of life, especially in younger patients and those with long-term hair loss, impacting both their physical and emotional well-being.

The Sinclair Shedding Scale is effective for diagnosing Alopecia Areata Incognita and monitoring treatment success.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

Women with alopecia areata have poor blood flow, possibly due to nerve inflammation.

Alopecia areata impacts mental well-being more due to perceptions and stigma than disease severity.